Narrow your search

Library

KCE (2)

UGent (2)

KU Leuven (1)

LUCA School of Arts (1)

Odisee (1)

Thomas More Kempen (1)

Thomas More Mechelen (1)

UCLouvain (1)

UCLL (1)

ULiège (1)

More...

Resource type

book (2)


Language

English (2)


Year
From To Submit

2005 (1)

2004 (1)

Listing 1 - 2 of 2
Sort by
Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality
Author:
ISBN: 1280947357 9786610947355 0335226558 9780335226559 9780335214655 0335214657 9780335214662 0335214665 9781280947353 0335214657 0335214665 661094735X Year: 2004 Publisher: Maidenhead : Open university press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgetsTaking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on the efficiency, quality, equity and cost of pharmaceutical care.Regulating Pharmaceuticals in Europe is an important book for students of health policy, regulation and management, and for health managers and policy makers.

Ethics and the pharmaceutical industry
Authors: ---
ISBN: 9780521854962 0521854962 9780511610769 9780521708883 0511610769 0511137575 9780511137570 0511135408 9780511135408 0511133995 9780511133992 0511167768 9780511167768 0511134436 9780511134432 9786610437115 6610437114 0521708885 1280437111 9781280437113 0511311907 9780511311901 1107155185 9781107155183 Year: 2005 Publisher: Cambridge ; New York, NY : Cambridge University Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Despite the pharmaceutical industry's notable contributions to human progress, including the development of miracle drugs for treating cancer, AIDS, and heart disease, there is a growing tension between the industry and the public. Government officials and social critics have questioned whether the multibillion-dollar industry is fulfilling its social responsibilities. This doubt has been fueled by the national debate over drug pricing and affordable healthcare, and internationally by the battles against epidemic diseases, such as AIDS, in the developing world. Debates are raging over how the industry can and should be expected to act. The contributions in this book by leading figures in industry, government, NGOs, the medical community, and academia discuss and propose solutions to the ethical dilemmas of drug industry behavior. They examine such aspects as the role of intellectual property rights and patent protection, the moral and economic requisites of research and clinical trials, drug pricing, and marketing.

Listing 1 - 2 of 2
Sort by